Breast Cancer-targets And Therapy

Journal Title：Breast Cancer-targets And Therapy

"Breast Cancer: Targets and Therapy," with its open-access nature, provides a valuable resource for medical researchers, clinicians, and patients with breast cancer. The journal covers comprehensive research from basic biological mechanisms to clinical applications, committed to promoting innovation and progress in the field of breast cancer treatment.

The journal pays special attention to precision medicine and personalized treatment plans, emphasizing in-depth research on molecular targets of breast cancer and how to translate these research findings into effective clinical treatments. In addition, the journal encourages the publication of research on new drug development, drug sensitivity, resistance mechanisms, and new therapeutic technologies, aiming to provide more treatment options for patients with breast cancer.

《乳腺癌：靶点与治疗》以其开放获取的特性，为广大医学研究者、临床医生和乳腺癌患者提供了一个宝贵的资源。该期刊涵盖了从基础生物学机制到临床应用的全方位研究，致力于推动乳腺癌治疗领域的创新和进步。

期刊特别关注精准医疗和个体化治疗方案，强调对乳腺癌分子靶点的深入研究，以及如何将这些研究成果转化为临床上的有效治疗。此外，期刊还鼓励发表关于新药开发、药物敏感性、耐药性机制以及新型治疗技术的研究，旨在为乳腺癌患者提供更多的治疗选择。

Breast Cancer-targets And Therapy由Dove Medical Press出版商出版，收稿方向涵盖ONCOLOGY全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 16 Weeks ，影响因子指数3.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。